title: Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
abstract: HOXB13 (G84E) was reported to significantly increase risk for prostate cancer. The goal of the current analysis was to assess the prevalence of G84E in ethnically-diverse high-risk men undergoing prostate cancer screening and place the carrier frequency within the context of prevalence estimates from reported studies to gain insight into the future role of this mutation in genetic counseling. PRAP is a prostate cancer screening program for unaffected men ages 35-69 with a family history of prostate cancer or African descent. HOXB13 G84E was genotyped by pyrosequencing in 649 PRAP participants with available DNA. Prevalence of the mutation was calculated for PRAP and for reported studies and exact binomial confidence intervals were generated. Prevalence of the G84E mutation in non-African PRAP men was 0.73 %. When placed in context of the literature, this was higher than reported controls. One G84E mutation carrier was notably of Hispanic background. While the HOXB13 G84E mutation may be rare, there may be a future role in genetic testing for this mutation after further studies of clinical utility in assessing prostate cancer risk.
authors: Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
authors: Elizabeth
authors: E
authors: Handorf
authors: Nicole
authors: N
authors: Crumpler
authors: Laura
authors: L
authors: Gross
authors: Veda N
authors: VN
authors: Giri
mesh_terms: D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D010375:Pedigree; D011471:Prostatic Neoplasms / Q000235:genetics*
chemical_list: C484414:HOXB13 protein, human; D018398:Homeodomain Proteins